EX-23.1 15 ubx-ex231_15.htm EX-23.1 ubx-ex231_15.htm

Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the following Registration Statements:

 

 

(1)

Registration Statement (Form S-3 No. 333-231893) and related Prospectus of Unity Biotechnology, Inc.,

 

(2)

Registration Statement (Form S-8 No. 333-224726) pertaining to the 2013 Equity Incentive Plan, the 2018 Incentive Award Plan and, 2018 Employee Stock Purchase Plan of Unity Biotechnology, Inc.,

 

(3)

Registration Statement (Form S-8 No. 333-230086) pertaining to the 2018 Incentive Award Plan and 2018 Employee Stock Purchase Plan of Unity Biotechnology, Inc.,

 

(4)

Registration Statement (Form S-8 No. 333- 237088) pertaining to the 2018 Incentive Award Plan and 2018 Employee Stock Purchase Plan of Unity Biotechnology, Inc.,

 

(5)

Registration Statement (Form S-8 No. 333-237474) pertaining to the 2020 Employment Inducement Incentive Plan of Unity Biotechnology, Inc., and

 

(6)

Registration Statement (Form S-8 No. 333- 250926) pertaining to the 2020 Employment Inducement Incentive Award Plan, as amended of Unity Biotechnology, Inc.;

 

of our report dated March 23, 2021, with respect to the financial statements of Unity Biotechnology, Inc. included in this Annual Report (Form 10-K) of Unity Biotechnology, Inc. for the year ended December 31, 2020.

/s/ Ernst & Young LLP

Redwood City, California

March 23, 2021